News | April 24, 2026
Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump
Growth was broad-based across segments
Growth was broad-based across segments
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Subscribe To Our Newsletter & Stay Updated
